ReviewCureus2024
Artificial Intelligence-Driven Advances in Coronary Calcium Scoring: Expanding Preventive Cardiology.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence in Cardiovascular Medicine: A Giant Step in Personalized Medicine?Journal of personalized medicine · 2026Review
- Visual coronary calcium scoring to support opportunistic CAD screening: comparative evaluation of three established systems and introduction of a novel scoring system.International journal of cardiology. Heart & vasculature · 2026Article
- Prognostication and clinical opportunities with AI for coronary artery calcium: a scoping review.BMJ digital health & AI · 2026Article
- Artificial intelligence in coronary artery calcification scoring: Current progress and future directions.Global cardiology science & practice · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary artery disease (CAD) remains a leading global cause of morbidity and mortality, underscoring the need for effective cardiovascular risk stratification and preventive strategies. Coronary artery calcium (CAC) scoring, traditionally performed using electrocardiogram (ECG)-gated cardiac computed tomography (CT) scans, has been widely validated as a robust tool for assessing cardiovascular risk. However, its application has been largely limited to high-risk populations due to the costs, technical requirements, and limited accessibility of cardiac CT scans. Recent advancements in artificial intelligence (AI) have introduced transformative opportunities to extend CAC detection to noncardiac CT scans, such as those performed for lung cancer screening, enabling broader and more accessible cardiovascular screening. This review provides a comprehensive analysis of AI-driven CAC detection, examining various types of AI models for CAC detection, like convolutional neural networks (CNNs) and U-Net architectures, and exploring the clinical, operational, and ethical implications of incorporating these technologies into routine practice. Technical challenges, including imaging variability, data privacy, and model bias, are discussed alongside essential areas for further research, such as standardization and validation across diverse populations. By leveraging widely available imaging data, AI-enabled CAC detection has the potential to advance preventive cardiology, supporting earlier risk identification, optimizing healthcare resources, and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.